Human Parvovirus B19

American Journal of Transplantation

Volumn 4, Issue 10 SUPPL., 2004, Pages 92-94

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ANTIVIRUS AGENT;

ANEMIA; BLOOD TRANSFUSION; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; ERYTHEMA INFECTIOSUM; ERYTHROCYTE APLASIA; FEVER; HEPATITIS; HUMAN; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; PANCYTOPENIA; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SERODIAGNOSIS; SEROPREVALENCE; SHORT SURVEY; VIRUS TRANSMISSION; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; IMMUNE DEFICIENCY; RECURRENT DISEASE; REVIEW; VIROLOGY; VIRUS INFECTION;

ANTIVIRAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; ERYTHEMA INFECTIOSUM; HUMANS; IMMUNOCOMPROMISED HOST; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RECURRENCE;

EID: 16644367528     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6135.2004.00731.x     Document Type: Short Survey

References (14)

1. Anderson LJ. Human parvoviruses. J Infect Dis 1990; 161: 603-608.
2. Bergen GA, Sakalosky PE, Sinnott JT. Transient aplastic anemia caused by Parvovirus B19 infection in a heart transplant recipient. J Heart Lung Transplant 1996; 15: 843-845.
3. Nour B, Green M, Michaels M et al. Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993; 56: 835-838.
4. Chang FY, Singh N, Gayowski T, Marino IR. Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients. Clin Transplant 1996; 10: 243-247.
5. Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 2001; 5: 320-330.
6. Lui SL, Luk WK, Cheung CY, Chan TM, Lai KN, Peiris JS. Nosocomial outbreak of Parvovirus B19 infection in a renal transplant unit. Transplantation 2001; 71: 59-64.
7. Frickhofen N, Arnold R, Hertenstein B, Wiesneth M, Young NS. Parvovirus B19 infection and bone marrow transplantation. Ann Hematol 1992; 64 (Suppl.): A121-A124.
8. Azzi A, Fanci R, Ciappi S, Zakrzewska K, Bosi A. Human Parvovirus B19 infection in bone marrow transplantation patients. Am J Hematol 1993; 44: 207-209.
9. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287-294.
10. Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet 1988; 2 (8621): 1159-1162.
11. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent Parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321: 519-523.
12. Janner D, Bork J, Baum M, Chinnock R. Severe pneumonia after heart transplantation as a result of human Parvovirus B19. J Heart Lung Transplant 1994; 13: 336-338.
13. Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 2000; 14: 586-591.
14. Ang HA, Apperley JF, Ward KN. Persistence of antibody to human Parvovirus B19 after allogeneic bone marrow transplantation: role of prior recipient immunity. Blood 1997; 89: 4646-4651.